CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −7,709 | $32.75 | $252K | 61,804 |
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,542 | 131,042 | ||
| 2026-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −4,167 | 104,167 | ||
| 2026-01-12 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −10,758 | $32.14 | $346K | 8,638 |
| 2026-01-12 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,348 | $1.08 | $7K | 68,152 |
| 2026-01-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,348 | $32.32 | $205K | 61,804 |
| 2026-01-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,348 | 38,092 | ||
| 2026-01-12 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −9,119 | $32.21 | $294K | 646,268 |
| 2026-01-12 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −7,117 | $33.15 | $236K | 639,151 |
| 2026-01-09 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,170 | $16.00 | $35K | 63,974 |
| 2026-01-09 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,170 | $33.27 | $72K | 61,804 |
| 2026-01-09 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,170 | 28,218 | ||
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +28,038 | $1.08 | $30K | 97,226 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +10,121 | $15.44 | $156K | 107,347 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +26,069 | $10.20 | $266K | 133,416 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +53,630 | $16.00 | $858K | 187,046 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +67,473 | $14.25 | $961K | 254,519 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −139,245 | $34.83 | $4.8M | 115,274 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −53,470 | $35.53 | $1.9M | 61,804 |
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −28,038 | 44,440 |
Page 9 of 17 · 321 trades